PDCD1 and neoplasm: Three classes of CD4+ T cells were identified via SCS, and it was found that CD4_1 upregulates TIGIT expression in tumors, CD4_2 expresses PD-1 (encoded by PDCD1) exclusively in tumors, and CD4_3 showed tumor-specific TIGIT and CD96 expression.